STOCKTON, CALIFORNIA/November 8, 2012 NEWSWIRE — Viratech, Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today that Kevin Buckman MD has taken the position of CEO for the Company.
As Founder of Viratech, Dr. Buckman understands the goals and opportunities for the Company. He developed many of the technologies that are key components of Viratech as well as holds a vast medical experience. He has had CEO and business experience that compliments his goals to move the Company forward.
“I am pleased to accept the appointment as Viratech’s CEO,” said Dr. Buckman. “I look forward to help make a difference using new medical innovations for more cost effective medical care, launching open source medical research, use of our Social Networks, and deployment of new technologies with our platforms to help many people,” he added.
Dr. Buckman is taking the helm for Matt Heindel, who has done an incredible job guiding the Company through the Research and Development Phase. Now that the company is posed for the revenue stage, Dr. Buckman’s knowledge and experience can help the Company with implementation of its business model. Mr. Heindel will stay on the Board of Directors to assist the company with his US and international experience and business operations expertise.
Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO completed his Medical School training at USC; he remained at USC for internship and 2nd year residency in Internal Medicine, and completed his training in Internal Medicine in 1981 at San Joaquin General Hospital, a UC Davis affiliate. He began his research in 1977 in the field of immunology, cancer, diabetes, and chronic diseases. His discovery of the role of Inflammation and Abnormal Cellular Environment in Cancer and immune disease in the 70’s has made him a leader in the field. His continuous research in this field has lead to his technologies in Non-Harmful Medicine with Early Diagnosis and Treatments, especially in the field of Women’s Health. He has published books including Find and Stop Breast Cancer, and Find and Stop Diabetes. He was recently a Speaker and Exhibitor at the International Cancer Conference and Forum 2010, Seoul, Korea, when he addressed many women’s health issues and solutions.
Dr. Buckman has served as Medical Director in various hospitals and institutions for over 25 years and has over 35 years of clinical experience. He has served as a member of the Executive Committee for six years at St. Dominic’s Hospital in Manteca, California. He has written many patents for new medical technologies. From 1986 to 1997 there were more than 50 Physicians on his roster under his Directorship at various institutions and hospitals. He also served as Medical Director for Dameron Hospital EMS Liaison from 2002 to 2003. He became Board Certified in Emergency Medicine and a Fellow of the American Board of Emergency Medicine in 1990.
He has received numerous Certifications and Specialty Training in the field of Medicine. He is a Fellow in the American Association of Integrated Medicine, and a certified Medical Review Officer. His other Specialties include: Internal Medicine, Forensic Medicine, Chinese Medicine and Acupuncture. He has over three decades of hospital and clinical experience and has served on over 15 hospital committees. He became Board Certified in Urgent Care Medicine and a Diplomat in 2006.
He has presented research, published articles and books in the field of medicine, given lectures at numerous hospitals and at International Medical Conferences, exhibited Breast Cancer technologies, and has traveled in 68 countries.
He has received Post Graduate Training at Stanford University School of Business, and attended seminars with the Securities Exchange Institute. He also serves on the Board of Directors for the California College of Natural Medicine. He was the first US Physician to be accepted into the European Group for Breast Cancer Screening after his research in this field was accepted for publication and presentation at their international conference in Cyprus. For many years he has worked internationally to advance a number of medical technologies. He has had a special interest in Non-Harmful early detection of disease, with a primary focus on Breast Cancer and Diabetes, his research in the field preventive medicine, and his expertise in non-harmful new methods of medical treatment for cancer. His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea. He is currently serving on the Industry Advisory Board for the University of Pacific School of Engineering and Computer Science and a Visiting Professor in Bioengineering, University of Pacific School of Engineering and Computer Science.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Kevin Buckman MD
Viratech, Corp.
Email Contact: info@viratech.org